Foghorn Therapeutics Inc (FHTX) — Financial Flexibility Index
Foghorn Therapeutics Inc (FHTX) has a Financial Flexibility Index of -0.07x as of June 2026. Free cash flow of $-18.85 Million (operating CF $-18.90 Million minus capex $50.00K) represents 0% of total liabilities ($284.43 Million). Check Foghorn Therapeutics Inc (FHTX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Foghorn Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Foghorn Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see FHTX cash flow metrics.
Annual Financial Flexibility Index for Foghorn Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Foghorn Therapeutics Inc. Explore FHTX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | $-86.05 Million | $-86.10 Million | $306.60 Million | ▲ +7.1% |
| 2024 | -0.30x | $-99.50 Million | $-100.41 Million | $329.51 Million | ▲ +6.2% |
| 2023 | -0.32x | $-116.88 Million | $-118.11 Million | $363.11 Million | ▼ -166.9% |
| 2022 | 0.48x | $194.82 Million | $193.61 Million | $404.77 Million | ▲ +533.7% |
| 2021 | -0.11x | $-46.94 Million | $-50.25 Million | $422.90 Million | ▲ +19.6% |
| 2020 | -0.14x | $-15.10 Million | $-31.29 Million | $109.41 Million | ▲ +66.4% |
| 2019 | -0.41x | $-45.37 Million | $-46.34 Million | $110.36 Million | ▼ -60.4% |
| 2018 | -0.26x | $-21.11 Million | $-22.65 Million | $82.33 Million | — |